Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TB vaccine development and the End TB Strategy: importance and current status
Helen A. Fletcher, Lewis K. Schrager
Transactions of the Royal Society of Tropical Medicine and Hygiene (2016) Vol. 110, Iss. 4, pp. 212-218
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Progress in biopharmaceutical development
Małgorzata Kęsik-Brodacka
Biotechnology and Applied Biochemistry (2017) Vol. 65, Iss. 3, pp. 306-322
Open Access | Times Cited: 292
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
Elisa Petruccioli, Thomas J. Scriba, Linda Petrone, et al.
European Respiratory Journal (2016) Vol. 48, Iss. 6, pp. 1751-1763
Open Access | Times Cited: 175
Transposon-mediated site-specific recombination: A defined in vitro system
Randall R. Reed
Cell (1981) Vol. 25, Iss. 3, pp. 713-719
Open Access | Times Cited: 227
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
Mohamed Osman, Anoop Mistry, Ada Keding, et al.
PLoS neglected tropical diseases (2017) Vol. 11, Iss. 5, pp. e0005527-e0005527
Open Access | Times Cited: 141
Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
Fabrizio Cantini, Carlotta Nannini, Laura Niccoli, et al.
Mediators of Inflammation (2017) Vol. 2017, pp. 1-15
Open Access | Times Cited: 127
Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design
Mohsen Karbalaei, Saman Soleimanpour, Seyed Abdolrahim Rezaee
Microbial Pathogenesis (2017) Vol. 112, pp. 20-29
Closed Access | Times Cited: 118
Next-Generation Vaccines Based on Bacille Calmette–Guérin
Natalie E. Nieuwenhuizen, Stefan H. E. Kaufmann
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 116
Selection of adjuvants for vaccines targeting specific pathogens
Indranil Sarkar, Ravendra Garg, Sylvia van Drunen Littel‐van den Hurk
Expert Review of Vaccines (2019) Vol. 18, Iss. 5, pp. 505-521
Open Access | Times Cited: 94
Resuscitation-promoting factors are important determinants of the pathophysiology inMycobacterium tuberculosisinfection
Andrew Rosser, Cordula Stover, Manish Pareek, et al.
Critical Reviews in Microbiology (2017) Vol. 43, Iss. 5, pp. 621-630
Open Access | Times Cited: 68
Immunological consequences of strain variation within the Mycobacterium tuberculosis complex
Leopold D. Tientcheu, Anastasia Koch, Mthawelenga Ndengane, et al.
European Journal of Immunology (2017) Vol. 47, Iss. 3, pp. 432-445
Open Access | Times Cited: 63
Tuberculosis elimination and the challenge of latent tuberculosis
Alberto Matteelli, Giorgia Sulis, Susanna Capone, et al.
La Presse Médicale (2017) Vol. 46, Iss. 2, pp. e13-e21
Closed Access | Times Cited: 62
Therapeutic Effect of Subunit Vaccine AEC/BC02 on Mycobacterium tuberculosis Post-Chemotherapy Relapse Using a Latent Infection Murine Model
Jinbiao Lu, Xiaonan Guo, Chunhua Wang, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 825-825
Open Access | Times Cited: 24
A Multi-Compartment Hybrid Computational Model Predicts Key Roles for Dendritic Cells in Tuberculosis Infection
Simeone Marino, Denise E. Kirschner
Computation (2016) Vol. 4, Iss. 4, pp. 39-39
Open Access | Times Cited: 44
First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment
Daria V. Vasina, Denis A. Kleymenov, Victor A. Manuylov, et al.
Vaccines (2019) Vol. 7, Iss. 4, pp. 166-166
Open Access | Times Cited: 38
Towards new TB vaccines
Benedict Brazier, Helen McShane
Seminars in Immunopathology (2020) Vol. 42, Iss. 3, pp. 315-331
Open Access | Times Cited: 35
RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection
Louis S. Ates, Fadel Sayes, Wafa Frigui, et al.
PLoS Pathogens (2018) Vol. 14, Iss. 6, pp. e1007139-e1007139
Open Access | Times Cited: 36
PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection
Anneliese S. Ashhurst, Thaigarajan Parumasivam, John Gar Yan Chan, et al.
PLoS ONE (2018) Vol. 13, Iss. 3, pp. e0194620-e0194620
Open Access | Times Cited: 34
Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder
Aneesh Thakur, Páll Thor Ingvarsson, S. Schmidt, et al.
Vaccine (2018) Vol. 36, Iss. 23, pp. 3331-3339
Closed Access | Times Cited: 33
Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors
Fadel Sayes, Catherine Blanc, Louis S. Ates, et al.
Cell Reports (2018) Vol. 23, Iss. 4, pp. 1072-1084
Open Access | Times Cited: 33
PE_PGRS33, an Important Virulence Factor of Mycobacterium tuberculosis and Potential Target of Host Humoral Immune Response
Eliza Kramarska, Flavia Squeglia, Flavio De Maio, et al.
Cells (2021) Vol. 10, Iss. 1, pp. 161-161
Open Access | Times Cited: 23
Optimizing antigen selection for the development of tuberculosis vaccines
Yang Yang, Yizhen Chen, Tian Xia
Cell Insight (2024) Vol. 3, Iss. 3, pp. 100163-100163
Open Access | Times Cited: 3
Embracing microbial exposure in mouse research
Matthew A. Huggins, Stephen C. Jameson, Sara E. Hamilton
Journal of Leukocyte Biology (2018) Vol. 105, Iss. 1, pp. 73-79
Open Access | Times Cited: 31
The never-ending story of the fight against tuberculosis: from Koch's bacillus to global control programs.
Mariano Martini, Giorgio Besozzi, Ilaria Barberis
PubMed (2018) Vol. 59, Iss. 3, pp. E241-E247
Closed Access | Times Cited: 31
IL-4 subverts mycobacterial containment inMycobacterium tuberculosis-infected human macrophages
Anil Pooran, Malika Davids, Andrew J. M. Nel, et al.
European Respiratory Journal (2019) Vol. 54, Iss. 2, pp. 1802242-1802242
Open Access | Times Cited: 29
RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice
Satria A. Prabowo, Hannah Painter, Andrea Zelmer, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top